AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
Indivior Solutions | Indivior PLC | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
Indivior, Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | FTC | $10,000,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | pharmaceuticals | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2015 | NY-ENV | $24,200 |
Indivior plc | Indivior PLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $300,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2021 | OFCCP | $560,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2009 | private lawsuit-federal | $28,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
AstraZeneca | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $175,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $35,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $150,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $92,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $100,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $65,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | IN-AG | $1,270,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
Hikma Pharmaceuticals | Hikma Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MULTI-AG | $150,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
ALEXION PHARMACEUTICALS, INC. | AstraZeneca | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $8,213 |
HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
GLAXOSMITHKLINE, LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | pharmaceuticals | environmental violation | 2005 | EPA | $21,125 |
ASTRAZENECA PLP | AstraZeneca | pharmaceuticals | environmental violation | 2021 | EPA | $18,960 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
DS SMITH | DS Smith PLC | paper and packaging | workplace safety or health violation | 2019 | OSHA | $13,047 |
Ensco Offshore Co. | Valaris | oilfield services and supplies | oil or gas drilling violation | 2015 | BSEE | $37,000 |
Ensco Offshore Co. | Valaris | oilfield services and supplies | oil or gas drilling violation | 2014 | BSEE | $70,000 |
Noble Drilling (U.S.) LLC | Noble Corp. | oilfield services and supplies | environmental violation | 2014 | DOJ | $12,200,000 |
Pride International Inc. and Pride Forasol S.A.S. | Valaris | oilfield services and supplies | Foreign Corrupt Practices Act | 2010 | DOJ_CRIMINAL | $32,625,000 |
Noble Corporation | Noble Corp. | oilfield services and supplies | Foreign Corrupt Practices Act | 2010 | DOJ_CRIMINAL | $2,590,000 |
Pride International Inc. | Valaris | oilfield services and supplies | Foreign Corrupt Practices Act | 2010 | SEC | $23,529,718 |
Noble Corporation | Noble Corp. | oilfield services and supplies | Foreign Corrupt Practices Act | 2010 | SEC | $5,576,998 |
Rowan Companies, Inc. | Valaris | oilfield services and supplies | environmental violation | 2007 | EPA | $9,000,000 |
Wood Group PSN Inc. | Wood Group | oilfield services and supplies | oil or gas drilling violation | 2017 | EPA | $9,500,000 |
FOSTER WHEELER, INC. | Wood Group | oilfield services and supplies | labor relations violation | 2001 | NLRB | $19,986 |
Ensco Offshore Co. | Valaris | oilfield services and supplies | oil or gas drilling violation | 2016 | BSEE | $35,000 |
FOSTER WHEELER MT CARMEL INC | Wood Group | oilfield services and supplies | environmental violation | 2002 | PA-ENV | $55,225 |
Foster Wheeler Robbins, Inc., Foster Wheeler Illinois, Inc., and Robbins Resource Recovery Partners, L.P. | Wood Group | oilfield services and supplies | air pollution violation | 2002 | IL-ENV | $450,000 |
Amec Foster Wheeler Energy Limited | Wood Group | oilfield services and supplies | Foreign Corrupt Practices Act | 2021 | DOJ_CRIMINAL | $18,375,000 |
Amec Foster Wheeler Limited | Wood Group | oilfield services and supplies | Foreign Corrupt Practices Act | 2021 | SEC | $10,100,000 |
AMEC | Wood Group | oilfield services and supplies | workplace safety or health violation | 2001 | OSHA | $7,000 |
ROWAN COMPANIES, INC., ROWAN GORILLA III | Valaris | oilfield services and supplies | workplace safety or health violation | 2011 | OSHA | $9,000 |
ROWAN COMPANIES, INC. - RIG #54 | Valaris | oilfield services and supplies | workplace safety or health violation | 2010 | OSHA | $9,165 |
NOBLE DRILLING SERVICES, INC. | Noble Corp. | oilfield services and supplies | workplace safety or health violation | 2012 | OSHA | $8,000 |
Foster Wheeler North America Corporation | Wood Group | oilfield services and supplies | PCB violation | 2009 | EPA | $5,400 |
Equilon Enterprises | Shell PLC | oil and gas | air pollution violation | 2015 | EPA | $900,000 |
Atlantic Richfield | BP | oil and gas | environmental violation | 2013 | EPA | $21,000,000 |
BP America | BP | oil and gas | hazardous waste violation | 2011 | EPA | $426,500 |
BP Products North America | BP | oil and gas | workplace safety or health violation | 2010 | OSHA | $50,610,000 |
BP Exploration & Production Inc. | BP | oil and gas | oil or gas drilling violation | 2014 | BSEE | $65,000 |
BP Exploration & Production, Inc. | BP | oil and gas | oil or gas drilling violation | 2013 | BSEE | $40,000 |